IXICO could target tenfold market expansion with £10m raise and AI platform pivot - broker

IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB), the neurology imaging and data analytics specialist, is raising £10 million to fund a strategic push beyond its established contract research business, with Cavendish arguing the move could unlock a market opportunity up to ten times larger than the company currently addresses. The fundraise, structured as a conditional equity placing with a retail offer open to raise up to a further £0.5 million, will bankroll a shift towards what the company calls a "TechBio" model, in which its proprietary AI-driven IXI Platform is licensed or subscribed to by larger companies operating in the broader clinical trial management and clinical decision support markets.